
IMMUNOLOGIC
DIAGNOSIS AND TYPING
OF
MULTIPLE MYELOMA AND A STUDY
OF SOME
OF ITS COMPLICATIONS
THESIS SUBMITTED FOR PARTIAL
FULFILMENT FOR THE
DOCTOR DEGREE IN CLINICAL PATHOLOGY
BY
Elham
Omer Hamed
M.B.B.Ch.&M.Sc. in clinical pathology
Faculty of Medicine, South Valley University
Under
supervision of
Prof.
Khadega Abdel-Shafea Abdel-Megeed
Professor of Clinical Pathology, Faculty of Medicine,
Assiut University
Dr.
Lobna Mohammad Tag-Eldeen
Lecturer of Clinical Pathology,
Faculty of Medicine, Assiut University
2000
INTRODUTION
AND AIM OF THE WORK
Multiple myeloma or
plasma cell myeloma is characterized by a neoplastic proliferation of a single
clone of plasma cells engaged in the production of a monoclonal protein. Multiple
myeloma accounts for about 10% of hematological malignancies. Bone pain anemia
&renal insufficiency constitute a triad that is strongly suggestive of
multiple myeloma. The minimal criteria for diagnosis of multiple myeloma
include the presence of at least 10% abnormal immature plasma cells in the bone
marrow and at least one of the following abnormalities:
The present study aims
at establishing the diagnosis of multiple myeloma in symptomatizing patients or
in cases with M component in their sera .
The newly introduced
technique of identification of a monoclonal immunoglobulin in the plasma cells
of bone marrow in multiple myeloma cases by immunoperxidase or immunofluorescence
offers an attractive and definitive test for diagnosis &differential
diagnosis of multiple myeloma particularly in the following conditions: -
Cases with benign of non
secretory myeloma, and patient exhibiting increased number of plasma cells in
the bone marrow as in paraproteinemia (MGUS), cases collagen diseases and in
certain infections.
LABORATORY
PROCEDURES:
We do the
following analysis
1st-
General investigations:
1- Peripheral hemogram.
2- Critical examination of bone marrow.
3- Assessment of liver functions.
4- Assessment of Kidney functions:
A- complete urine analysis.
B- serum urea, creatinine, urinary
creatinine
clearance was calculated, & serum
uric acid.
5- Serum calcium, phosphate and alkaline
phosphatase.
6- Total protein in urine, urinary
albumen & very low
conc. Albumin
7- Serum & urine IgG.
8- The calculation of albumin IgG
clearance & selectivity
index.
9- Tubular proteins:
A-Estimation of a1 macroglobulin
in urine.
B-Estimation of retinol binding
protein in urine.
C-Estimation of b2 microglobulin in urine.
2nd-
Special investigations:
1-screening
of sera for paraprotein & quantitation by
denstometry.
2-Test
for cryoglobulin & quantitation if present.
3-Detection
of Bence-Jones protein in urine and
identification of the type of light chain.
4-Sia
test for IgM macroglobulinaemia.
5-Serum
b2 microglobulin & LDH level.
6-Typing
of paraprotein in serum by immunofixation
electrophoresis.
7-
Quantitation of serum immunoglobulins IgG, IgA,
IgM.
8-Identification
of the bone marrow by
immunofluorescence or immunoperoxidase.